ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 179 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2024. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,862,000 | – | 35,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $98,242,000 | 23.93% |
| Rhenman & Partners Asset Management AB | 655,854 | $24,044,000 | 3.01% |
| Bellevue Group AG | 4,241,461 | $155,492,000 | 2.89% |
| Boxer Capital, LLC | 975,000 | $35,744,000 | 2.59% |
| Pentwater Capital Management LP | 2,478,261 | $90,853,000 | 1.42% |
| HAMILTON LANE ADVISORS LLC | 52,826 | $1,937,000 | 0.81% |
| Tekla Capital Management LLC | 213,562 | $7,829,000 | 0.34% |
| Granahan Investment Management | 154,628 | $5,669,000 | 0.31% |
| Spark Investment Management LLC | 64,900 | $2,379,000 | 0.30% |
| WASATCH ADVISORS LP | 630,397 | $23,110,000 | 0.22% |